Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo - PubMed (original) (raw)
. 2000 Oct 15;226(2):180-91.
doi: 10.1006/dbio.2000.9850.
Affiliations
- PMID: 11023679
- DOI: 10.1006/dbio.2000.9850
Free article
Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo
M I Lin et al. Dev Biol. 2000.
Free article
Abstract
Neurotrophin-3 (NT-3) is a member of the neurotrophin family of growth factors, best characterized by its survival- and differentiation-inducing effects on developing neurons bearing the trk C receptor tyrosine kinase. Through analysis of NT-3 and trk C gene-targeted mice we have identified NT-3 as critically regulating cardiac septation, valvulogenesis, and conotruncal formation. Although these defects could reflect cardiac neural crest dysfunction, the expression of NT-3 and trk C by cardiac myocytes prior to neural crest migration prompted analysis of cell-autonomous actions of NT-3 on cardiac myocytes. Retroviral-mediated overexpression of truncated trk C receptor lacking kinase activity was used to inhibit activation of trk C by endogenous NT-3, during early heart development in ovo. During the first week of chicken development, expression of truncated trk C reduced myocyte clone size by more than 60% of control clones. Direct mitogenic actions of NT-3 on embryonic cardiac myocytes were demonstrated by analysis of BrdU incorporation or PCNA immunoreactivity in control and truncated trk C-expressing clones. Inhibition of trk C signaling reduced cardiac myocyte proliferation during the first week of development, but had no effect at later times. These studies demonstrate that endogenous NT-3:trk C signaling regulates cardiac myocyte proliferation during cardiac looping and the establishment of ventricular trabeculation but that myocyte proliferation becomes NT-3 independent during the second week of embryogenesis.
Copyright 2000 Academic Press.
Similar articles
- Trk C signaling is required for retinal progenitor cell proliferation.
Das I, Sparrow JR, Lin MI, Shih E, Mikawa T, Hempstead BL. Das I, et al. J Neurosci. 2000 Apr 15;20(8):2887-95. doi: 10.1523/JNEUROSCI.20-08-02887.2000. J Neurosci. 2000. PMID: 10751441 Free PMC article. - Effects of neurotrophin and neurotrophin receptor disruption on the afferent inner ear innervation.
Fritzsch B, Silos-Santiago I, Bianchi LM, Farinas I. Fritzsch B, et al. Semin Cell Dev Biol. 1997;8:277-84. Semin Cell Dev Biol. 1997. PMID: 11542690 Review. - Signaling pathways controlling second heart field development.
Rochais F, Mesbah K, Kelly RG. Rochais F, et al. Circ Res. 2009 Apr 24;104(8):933-42. doi: 10.1161/CIRCRESAHA.109.194464. Circ Res. 2009. PMID: 19390062 Review.
Cited by
- Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.
Aridgides D, Salvador R, PereiraPerrin M. Aridgides D, et al. Cell Microbiol. 2013 Aug;15(8):1357-66. doi: 10.1111/cmi.12119. Epub 2013 Mar 14. Cell Microbiol. 2013. PMID: 23414299 Free PMC article. - Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart disease.
Werner P, Paluru P, Simpson AM, Latney B, Iyer R, Brodeur GM, Goldmuntz E. Werner P, et al. Hum Mutat. 2014 Dec;35(12):1459-68. doi: 10.1002/humu.22688. Epub 2014 Nov 7. Hum Mutat. 2014. PMID: 25196463 Free PMC article. - Diverse dependencies of developing Merkel innervation on the trkA and both full-length and truncated isoforms of trkC.
Cronk KM, Wilkinson GA, Grimes R, Wheeler EF, Jhaveri S, Fundin BT, Silos-Santiago I, Tessarollo L, Reichardt LF, Rice FL. Cronk KM, et al. Development. 2002 Aug;129(15):3739-50. doi: 10.1242/dev.129.15.3739. Development. 2002. PMID: 12117822 Free PMC article. - Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
Fujitani M, Otani Y, Miyajima H. Fujitani M, et al. Biomolecules. 2021 Nov 19;11(11):1730. doi: 10.3390/biom11111730. Biomolecules. 2021. PMID: 34827728 Free PMC article. Review. - Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.
Kermani P, Hempstead B. Kermani P, et al. Trends Cardiovasc Med. 2007 May;17(4):140-3. doi: 10.1016/j.tcm.2007.03.002. Trends Cardiovasc Med. 2007. PMID: 17482097 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous